(Washington, D.C.) — Pharmaceutical Care Management Association President and CEO Mark Merritt issued the following statement on the Administration’s announcement to provide Medicare Part D plans additional flexibility in designing Medicare Part D formularies around medical indications. “While PCMA is
Sean Stephenson Director, State Affairs Sean Stephenson is the Director, State Affairs for PCMA. In this role he coordinates and supports state activity for the state affairs team and develops valuable resources for our members. He brings over 17 years
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is announcing the additions of Jack Linehan as General Counsel, Agnita Kote as Chief Financial Officer, Zach Pleasant as Director, Technology and Operations, and the promotion of Amanda Frost to Vice
Christy Beach Executive Assistant to JC Scott, the President & CEO of PCMA and Board Liaison Christy Beach is the Executive Assistant to JC Scott, the President & CEO of PCMA as well as Board Liaison. Prior to joining PCMA,
Tonia Sorrell-Neal Senior Director, State Affairs Tonia Sorrell-Neal is Senior Director, State Affairs for PCMA. She comes to the association with more than 20 years of association management and lobbying experience in the construction industry with a primary focus in
Total US expenditures on pharmaceutical drugs…were $480 billion…Two-thirds of this total was captured by drug manufacturers in the form of net revenues.
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA), the national association representing pharmacy benefit managers (PBMs), released the following statement on the United States Supreme Court decision in Rutledge v. Pharmaceutical Care Management Association (PCMA). “We are disappointed in the Court’s
WHAT: Some of the nation’s top health care CEOs discuss reimagining the global pharmaceutical supply chain. The live webinar series will highlight drug executives’ thoughts and strategies for addressing the challenges industries face in the COVID-19 era. PCMA will host
Dr. Lawton Robert Burns, a professor at the University of Pennsylvania Wharton School and an expert on the medical and prescription drug supply chains, took a deep dive into pharmacy benefit companies and shed light on the role of PBMs.
©2024 PCMA. All Rights Reserved.
